Study Termination. This study may be terminated at any time by the Sponsor if there is sufficient reasonable cause. Circumstances that may warrant termination include, but are not limited to: · Determination of unexpected, significant, or unacceptable risk to subjects. · Failure of enrollment · Administrative reasons · Plans to modify, suspend or discontinue the development of the study drug. In addition, individual study sites may be terminated from study participation for reasons including, but not limited to the following: · Failure to enter subjects at an acceptable rate. · Insufficient adherence to protocol requirements. · Incomplete and/or non-evaluable data. In all cases, the terminating parties will provide written notification documenting the reason for study termination to all the relevant parties. Should the study or an individual site be prematurely closed, all study materials (completed, partially completed, and blank CRFs, study drug, etc.) must be returned to the Sponsor (or its designee).
Appears in 4 contracts
Samples: Clinical Trial Services Agreement (Radius Health, Inc.), Clinical Trial Services Agreement (Radius Health, Inc.), Clinical Trial Services Agreement (Radius Health, Inc.)
